Audit 310798

FY End
2023-09-30
Total Expended
$5.14M
Findings
0
Programs
6
Organization: Asante Health System (OR)
Year: 2023 Accepted: 2024-06-28
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Contacts

Name Title Type
PG1NM2W2BBG3 Heather Rowenhorst Auditee
5417895098 Kelsey Reynolds Auditor
No contacts on file

Notes to SEFA

Title: (1) Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The accompanying schedule of expenditures of federal awards includes all federal funds expended by the Company during the year ended September 30, 2023. For purposes of the Schedule, federal funds include all grants, contracts, loans, and loan guarantee agreements entered into directly between the Company and agencies and departments of the federal government as well as any federal awards passed through other governmental agencies. De Minimis Rate Used: N Rate Explanation: The Company has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Asante Health System and Subsidiaries (the Company) under programs of the federal government for the year ended September 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200 (2 CFR 200), Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Company, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Company.
Title: (2) Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The accompanying schedule of expenditures of federal awards includes all federal funds expended by the Company during the year ended September 30, 2023. For purposes of the Schedule, federal funds include all grants, contracts, loans, and loan guarantee agreements entered into directly between the Company and agencies and departments of the federal government as well as any federal awards passed through other governmental agencies. De Minimis Rate Used: N Rate Explanation: The Company has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The accompanying schedule of expenditures of federal awards includes all federal funds expended by the Company during the year ended September 30, 2023. For purposes of the Schedule, federal funds include all grants, contracts, loans, and loan guarantee agreements entered into directly between the Company and agencies and departments of the federal government as well as any federal awards passed through other governmental agencies.
Title: (3) Indirect Cost Rate Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The accompanying schedule of expenditures of federal awards includes all federal funds expended by the Company during the year ended September 30, 2023. For purposes of the Schedule, federal funds include all grants, contracts, loans, and loan guarantee agreements entered into directly between the Company and agencies and departments of the federal government as well as any federal awards passed through other governmental agencies. De Minimis Rate Used: N Rate Explanation: The Company has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. The Company has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Title: (4) Personal Protective Equipment Receipts (unaudited) Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The accompanying schedule of expenditures of federal awards includes all federal funds expended by the Company during the year ended September 30, 2023. For purposes of the Schedule, federal funds include all grants, contracts, loans, and loan guarantee agreements entered into directly between the Company and agencies and departments of the federal government as well as any federal awards passed through other governmental agencies. De Minimis Rate Used: N Rate Explanation: The Company has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. The Company has not received material donated personal protective equipment (PPE) from federal sources.